MDXG vs TCMD
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
MDXG presents a stark divergence between fundamental value and market sentiment. With a Piotroski F-Score of 4/9 (Stable) and an exceptionally clean balance sheet (Debt/Equity 0.09), the company is financially healthy and significantly undervalued relative to its Intrinsic Value of $9.44 and Analyst Target of $9.67. However, the assessment is tempered to neutral due to a severe technical collapse (0/100 trend) and bearish insider activity, suggesting that while the stock is a value bargain, it lacks a current catalyst for reversal.
TCMD exhibits a stable financial foundation with a Piotroski F-Score of 4/9 and an exceptionally strong balance sheet characterized by very low leverage (Debt/Equity 0.07). While the company shows robust revenue growth of 21% and high gross margins, the stock is currently trading at a premium to its Intrinsic Value ($24.19) and significantly above its Graham Number ($13.42). The valuation is further strained by an extreme PEG ratio of 17.79, suggesting the price has outpaced fundamental growth. Imminent regulatory risks regarding CMS Prior Authorization (PAR) requirements starting April 2026 and bearish insider activity create significant headwinds.
Compare Another Pair
Related Comparisons
MDXG vs TCMD: Head-to-Head Comparison
This page compares MiMedx Group, Inc. (MDXG) and Tactile Systems Technology, Inc. (TCMD) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.